Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: July 13, 2026, to July 17, 2026
Subject: Disclosure of transactions in own shares (share repurchases) under the Company's ongoing buyback programme.
Key Financial Metrics and Transaction Details
This filing reports specific share repurchase activity rather than comprehensive financial performance metrics (revenue, profit, cash flow, or debt levels are not included in this document).
| Trading Venue | Total Shares Purchased | Price Range (High/Low) | Volume Weighted Average Price |
|---|---|---|---|
| US Trading Venues | 165,000 | USD 107.39 / USD 103.09 | USD 105.70 (approx.)* |
| London Trading Venues | 62,762 | GBP 80.10 / GBP 77.05 | GBP 79.09 (approx.)* |
| Total | 227,762 | - | - |
*Average price calculated based on daily VWAPs provided in the text.
Programme Context: These purchases are part of a share buyback programme announced on February 17, 2026, with an aggregate authorization of up to EUR 1 billion. All repurchased shares are to be cancelled.
Material Changes
The filing does not report material changes to the Company's financial position, operations, or strategy compared to prior periods. It solely documents the execution of the authorized share buyback programme during the specified week.
Guidance, Outlook, and Risks
Outlook: The Company continues to execute its EUR 1 billion share repurchase programme.
Risks and Contingencies: No new risks or contingencies are disclosed in this filing. The transactions were conducted in accordance with the Market Abuse Regulation (Regulation (EU) No 596/2014).
Key Facts for Investor Verification
- Share Count Reduction: Verify the impact of 227,762 cancelled shares on the total outstanding share count and earnings per share (EPS).
- Programme Remaining Capacity: Confirm the remaining balance of the EUR 1 billion buyback authorization after these transactions.
- Execution Costs: Review the average purchase prices (USD ~105.70 and GBP ~79.09) against the Company's internal cost of capital or target valuation metrics.
- Regulatory Compliance: Note that full transaction details are available via the referenced London Stock Exchange RNS link for granular audit.